Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone

British Journal of Haematology

Volumn 91, Issue 4, 1995, Pages 827-833

  Nielsen, P ^a   Fischer, R ^a   Engelhardt, R ^a   Tondury P ^b   Gabbe, E E ^a   Janka, G E ^c  

^a Physlologisch Chemisches Institut ^*  (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

biomagnetometry; deferiprone; iron; LI; thalassaemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; IRON;

ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IRON STORAGE; LIVER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SPLEEN;

ADULT; AGED; BIOPHYSICS; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FEMALE; FERRITIN; HEMOSIDEROSIS; HUMAN; IRON; IRON CHELATING AGENTS; LIVER; MAGNETICS; MALE; MIDDLE AGE;

EID: 0028862502     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1995.tb05396.x     Document Type: Article

References (25)

1. Long‐term assessment of efficacy and safety of LI, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial
2. Efficacy and possible adverse effects of the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one (L1) in thalassemia major
3. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major
4. Magnetic susceptibility measurement of human iron stores. New England
5. Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta‐thalassemia major and iron overload
6. Depletion of excessive liver iron stores with desferroxamine
7. MRI‐sequences for liver iron quantification: studies in aqueous iron solutions, iron overloaded rats and patients with hereditary hemochromatosis
8. The calibration problem in liver iron susceptometry
9. Liver iron quantification in the diagnosis and therapy control of iron overload patients
10. Evaluation of computed tomography in the assessment of liver iron overload: a study of 46 cases of idiopathic hemochromatosis
11. Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging
12. Diagnosis and clinical evaluation of iron overload
13. l,2‐Dimethyl‐3‐hydroxypyrid‐4‐one, an orally active chelator for treatment of iron overload
14. Long‐term trial with the oral iron chelator 1,2‐dimethyl‐3‐hydroxy‐pyrid‐4‐one. I. Iron chelation and metabolic studies
15. Simple synthesis of the potent iron chelators 1‐alkyl‐3‐hydroxy‐2‐methylpyrid‐4‐ones
16. Liver volume measurement by ultrasonography in normal subjects and alcoholic patients
17. Noninvasive liver‐iron quantification by computed tomography in iron‐overloaded rats
18. Iron‐chelation therapy with oral deferiprone in patients with thalassemia major
19. Comparison of oral chelator LI and desferrioxamine in iron‐loaded patients
20. Biomagnetic susceptometer with SQUID instrumentation. IEEE
21. Ferrioxamine excretion in iron loaded man
22. Haemosiderin
23. L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia major
24. Binding of serum ferritin to concanavalin A: patients with homzygous β thalassaemia and transfusional iron overload